About us

The IBD Registry is a not-for-profit company set up by and owned by three member organisations: The British Society of Gastroenterology, the Royal College of Physicians and Crohn’s and Colitis UK.

Why the RCP is a founder member of the Registry

Our Board

Our organisation is governed by our three member organisations, who provide two directors each. In January 2020, three directors stepped down at the end of their terms and three new ones were appointed.  The new directors are Sarah Sleet and Joanne Fillingham for Crohn’s & Colitis UK and Dr John Dean for the Royal College of Physicians. More information on our new directors will be posted shortly. Information on the other serving directors and the excutive leadership team is below.

Sarah Sleet

Sarah Sleet

Crohn's and Colitis UK

About Sarah

Sarah is the Chief Executive for Crohn’s and Colitis UK. Sarah is an experienced and successful Chief Executive, and has worked with a broad range of health and patient groups and European patient organisations, as well as government advisory and research bodies. She has also built expertise in education, social and economic policy, scientific research, income generation and campaigning. She lives in Oxford and is Chair of Community Christmas, a small charity working to alleviate loneliness at Christmas. 

Dr Barney Hawthorne (Chair of the Board)

Dr Barney Hawthorne (Chair of the Board)

British Society of Gastroenterology

About Barney

Dr Hawthorne studied medicine at Queens’ College Cambridge, and went on to do his clinical training at the University of Oxford, qualifying in 1983. He trained in general medicine and gastroenterology in Nottingham and Manchester, and did research work in Nottingham on eicosanoids in ulcerative colitis, with Prof Chris Hawkey, leading to an MD.  He took up a consultant post at the University Hospital of Wales in Cardiff in 1995, where he has further built up the large inflammatory bowel disease clinic established by Prof John Rhodes. His clinical interests are inflammatory bowel disease and intestinal failure. As well as developing the IBD services in Cardiff, he has set up and developed the Cardiff Intestinal Failure service, which now supports 130 patients on long-term home parenteral nutrition.

He is currently chair of the IBD section committee of the BSG, and is co-lead for the BSG IBD guidelines writing group (2018). He chairs the Health Care Professional Advisory Panel for Crohn’s Colitis UK, and also sits on the Medical Research Grants committee for Crohn’s Colitis UK. He sits of the IBD UK committee, and the IBD Wales committee. He is also a director and board member of the IBD Registry co., representing the BSG. His research interests include clinical trials of immunosuppressive therapy in IBD, and the natural history of inflammatory bowel disease.

John Dean

John Dean

Royal College of Physicians

About John

John is a physician and Deputy Medical Director at East Lancashire Hospitals NHS Trust. He is a Trustee Councillor of the Royal College of Physicians (RCP) in addition to being their Clinical Director of Quality Improvement and Patient Safety. John has had a long interest in chronic disease management at a population level, and led a number of local, regional and national initiatives in this area. He has extensive Governance and Board experience within the NHS and arms-length bodies. He spent 12 months at the Institute for Healthcare Improvement (IHI) and Harvard University, and has worked in QI initiatives across the Department of Health, Royal Colleges, NHS NW, IHI and the Health Foundation. He played a major role in the development of the Advancing Quality Alliance (AQuA) as clinical lead, faculty and non-executive board member. John was appointed Clinical Lead for QI and Patient Safety at the Royal College of Physicians in 2017. He is an associate editor of Future Healthcare Journal. He is a member of a number of national working groups and boards for quality and patient safety. He is particularly interested to ensure clinical teams use high quality data to drive local quality improvement projects and programmes, and that they have the skills to do this. He is a Health Foundation/IHI fellow and Q fellow.

Prof. Alan Lobo

Prof. Alan Lobo

British Society of Gastroenterology

About Alan

Professor Alan Lobo has been Consultant Gastroenterologist at Sheffield Teaching Hospitals since 1994 and is also Professor of Gastroenterology at the University of Sheffield. He undertook undergraduate training at Guy’s Hospital, London, qualifying in 1984 and postgraduate training in Cambridge, Oxford, Leeds and Bristol.

He leads the IBD service in Sheffield, which has seen considerable, multidisciplinary development – including the introduction of IBD nurse specialists in 1998. Research interests have included genomic and proteomic influences, clinical and immunologic aspects of biologic therapy, psychological morbidity and decision making in IBD.

Professor Lobo was a lead author for BSG guidelines for IBD in 2004 and was a NICE Guideline Development Group member for Crohn’s disease in 2012. He chaired the NICE Guideline Development Group for ulcerative colitis in 2013. He has been a member of the BSG IBD section committee on two occasions and the BSG IBD Clinical Research Group as well as an elected member of BSG Council.

Dr Andy Cole

Dr Andy Cole

Royal College of Physicians

About Andy

Dr Andy Cole is a Consultant Gastroenterologist at the Royal Derby Teaching Hospital. He did his undergraduate studies in Cambridge and UCL London and trained in Gastroenterology in Bristol with Richard Harvey, Dunedin New Zealand with Prof Gill Barbezat and in Nottingham with Professor Chris Hawkey.  He has a longstanding clinical and research interest in Inflammatory Bowel Diseases. He undertook his MD thesis research in IBD inflammatory responses and their drug therapy.

He is an author of the 2010 BSG IBD Guidelines and the ECCO  2010 Evidence based consensus on the diagnosis and management of Crohn’s disease special situations- IBD guidelines.  He continues to be research active in both multicentre drug studies, pharmacovigilance studies and endotherapy studies. He is past secretary of the BSG IBD section. He is past president of the Derby Medical Society and is immediate past president of the Midlands Gastroentrology Association.

Joanne Fillingham

Joanne Fillingham

Crohn's & Colitis UK

Biography to follow

Our executive leadership team

Our executive leadership team balances business and clinical knowledge in a combination that allows us best to pursue our purpose.

Liz Dobson

Liz Dobson

Chief Executive Officer

About Liz

Chief Executive Officer – Liz brings to the IBD Registry 20 years of executive and senior management experience from the private and not-for-profit sector, including early stage businesses. She brings both the leadership and business skills that the IBD Registry needs as a new non-profit company, combined with a robust background in operations, and technical understanding that will be of huge benefit to the Registry as it embarks on this next stage of its growth.  Liz’s experience is underpinned by a Sloan Fellow MSc (Business) from London Business School, and BSc (Maths) first class honours.

Dr Stuart Bloom

Dr Stuart Bloom

Medical Director

About Stuart

Stuart has been  a consultant gastroenterologist at UCL hospitals in London since 1996. He was chair of the IBD section of the British Society of Gastroenterology from 2006-2009 and is currently National Specialty Lead for Gastroenterology at the NIHR Comprehensive Clinical Research Network (NIHR-CCRN). He has a longstanding interest in how we use technology to record outcomes from the clinical consultation and in defining local and national populations of patients with Inflammatory bowel disease with a view to improving treatment and outcomes.

Dr Fraser Cummings

Dr Fraser Cummings

Clinical Lead for Studies & Collaboration

About Fraser

Fraser has been a consultant gastroenterologist at University Hospital Southampton since 2009, having completed his clinical and research training in Oxford. As clinical lead for IBD services at UHS he is responsible for developing all aspects of the clinical service. Through this experience he has come to appreciate how critical accurate data is to the provision of high quality patient care as well as informing the development of new care pathways and local services. He is interested in how we record and use data to improve outcomes for patients.

Dr Keith Bodger

Academic Lead

Funding

Funding for the IBD Registry has been provided by the British Society of Gastroenterology, Crohn’s and Colitis UK, AbbVie, Allergan, Biogen, Celltrion, Dr Falk, Janssen, MSD, Napp, Otsuka, Pfizer, Pharmacosmos, Shire, Takeda, Tillotts and Vifor as well as private donors. We would like to thank all of these organisations and individuals for their invaluable support.

IBD Registry Ltd is a not-for-profit company limited by guarantee - Company Number 11197749.
Our Registered Address is 3 St Andrews Place, Regent’s Park, London NW1 4LB. VAT Number 291683766.